Article: Enablers and barriers for supply chain finance investments in Pharma 4.0: a study in the Indian context using total interpretive structural modelling Journal: International Journal of Revenue Management (IJRM) 2024 Vol.14 No.2 pp.95 - 126 Abstract: In this study, we examine the conditions that surround the investment made into Pharma 4.0 by the supply chain finance institution. This study analyses the various enablers and barriers that would affect the implementation of Pharma 4.0, through the investment by an SCF institution, in the Indian pharmaceutical manufacturing firms. To establish the linkage between the factors, total interpretive structural modelling is used. MICMAC is used to prioritise the factors and develop suitable strategies. The findings show that a combined effort of all the stakeholders is required for eliminating the barriers to the implementation. The findings also give information about the various enablers that would help catalyse the adoption of Pharma 4.0. This study talks about how SCF investment, usually seen as a short-term investment, can be used with the long-term perspective to gain benefits and incentives through investment in Pharma 4.0 by properly monitoring and controlling the influencing factors. Inderscience Publishers - linking academia, business and industry through research

Title: Enablers and barriers for supply chain finance investments in Pharma 4.0: a study in the Indian context using total interpretive structural modelling

Authors: Jude Jegan Joseph Jerome; Vandana Sonwaney; O.N. Arunkumar

Addresses: Symbiosis Institute of Operations Management (SIOM), Symbiosis International (Deemed University) (SIU), Nashik, India ' Symbiosis Institute of Operations Management (SIOM), Symbiosis International (Deemed University) (SIU), Nashik, India ' Symbiosis Institute of Business Management (SIBM), Symbiosis International (Deemed University) (SIU), Bengaluru, India

Abstract: In this study, we examine the conditions that surround the investment made into Pharma 4.0 by the supply chain finance institution. This study analyses the various enablers and barriers that would affect the implementation of Pharma 4.0, through the investment by an SCF institution, in the Indian pharmaceutical manufacturing firms. To establish the linkage between the factors, total interpretive structural modelling is used. MICMAC is used to prioritise the factors and develop suitable strategies. The findings show that a combined effort of all the stakeholders is required for eliminating the barriers to the implementation. The findings also give information about the various enablers that would help catalyse the adoption of Pharma 4.0. This study talks about how SCF investment, usually seen as a short-term investment, can be used with the long-term perspective to gain benefits and incentives through investment in Pharma 4.0 by properly monitoring and controlling the influencing factors.

Keywords: supply chain finance; SCF; pharmaceutical industry; Pharma 4.0 adoption enablers and barriers; total interpretive structural model; total interpretive structural modelling; TISM; MICMAC.

DOI: 10.1504/IJRM.2024.138707

International Journal of Revenue Management, 2024 Vol.14 No.2, pp.95 - 126

Received: 28 Mar 2023
Accepted: 15 Jul 2023
Published online: 29 May 2024 *

Full-text access for editors Full-text access for subscribers Purchase this article Comment on this article

Title: Enablers and barriers for supply chain finance investments in Pharma 4.0: a study in the Indian context using total interpretive structural modelling

Keep up-to-date